Skip to content
healthcare.dev

Repaglinide

NDC 60687-560, Repaglinide, tablet, from American Health Packaging.

Product NDC
60687-560
Status
Listed
Labeler
American Health Packaging
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203820
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60687-560 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REPAGLINIDE1 mg/1

Pharmacologic classes

Glinide [EPC]; Potassium Channel Antagonists [MoA]

Package NDCNDC-11Package
60687-560-216068705602130 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-560-21) / 1 TABLET in 1 BLISTER PACK (60687-560-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dd1d8337-9903-4b8a-a9ea-569e4d134e74
  • NADAC price for package 60687056021

    GET /v1/drugs/nadac/60687056021

Use it

Look up 60687-560 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60687-560 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60687-560. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.